1.
EMJ-Emirates Medical Journal. 2003; 21 (1): 83-92
en Inglés
| IMEMR
| ID: emr-62113
2.
EMJ-Emirates Medical Journal. 2002; 20 (3): 393-8
en Inglés
| IMEMR
| ID: emr-59353
Asunto(s)
Inhibidores de la Ciclooxigenasa , Ergotamina , Eritromicina , Gentamicinas , Mefloquina , Metisergida , Metoprolol , Warfarina
3.
EMJ-Emirates Medical Journal. 2000; 18 (3): 242-245
en Inglés
| IMEMR
| ID: emr-53810
4.
EMJ-Emirates Medical Journal. 1999; 17 (1): 47-49
en Inglés
| IMEMR
| ID: emr-50732
5.
EMJ-Emirates Medical Journal. 1999; 17 (2): 96-100
en Inglés
| IMEMR
| ID: emr-50743
6.
EMJ-Emirates Medical Journal. 1999; 17 (3): 177-180
en Inglés
| IMEMR
| ID: emr-50764
Asunto(s)
Tramadol/farmacología , Aspirina/efectos adversos , Codeína/efectos adversos , Acetaminofén/efectos adversos , Gentamicinas/efectos adversos , Indometacina/efectos adversos , Nicotina/efectos adversos , Ácido Fólico/administración & dosificación , Inhibidores de la Proteasa del VIH , Fumar/efectos adversos , Nicotina/administración & dosificación , Infecciones por VIH/tratamiento farmacológico
7.
EMJ-Emirates Medical Journal. 1997; 15 (1): 44-6
en Inglés
| IMEMR
| ID: emr-44656
8.
EMJ-Emirates Medical Journal. 1997; 15 (2): 91-95
en Inglés
| IMEMR
| ID: emr-44668
9.
EMJ-Emirates Medical Journal. 1997; 15 (3): 158-60
en Inglés
| IMEMR
| ID: emr-44681
10.
EMJ-Emirates Medical Journal. 1996; 14 (1): 15-20
en Inglés
| IMEMR
| ID: emr-41006
RESUMEN
The distribution of polymorphic N-acetyltransferase [NAT2] phenotypes was studied in 118 unrelated UAE nationals. Phenotypes were assigned by determination of the 5-acetylamino-6-formylamino-3-methyluracil/1 -methylxanthine [AFMU/1X] urinary molar excretion ratio after oral ingestion of caffeine. The prevalence of the slow acetylator phenotype was found to be 61%. The fast acetylator phenotype included many individuals with intermediate acetylating capacity who could be cautiously identified as heterozygotes. The possible role of NAT2 genotype in the aetiology of cancer is discussed